| Brian
Daniels, M.D.
Senior
Vice President, Global Development & Medical Affairs
 Brian
Daniels is senior vice president, Global Development and Medical Affairs, and a member
of the Management Council, the company’s most senior leadership
group. In this position, he helps drive the company’s focus
on science and medicine as a central strategy of our next-generation
BioPharma vision.
“Pharmaceutical
R&D is a long and complex process,” says Brian. “My
role is to make the internal workings as simple as possible so
that good, bright people can make substantial contributions to
patient care. Our goal is to produce medicines that change the
standard of care in a meaningful way for physicians, provide
economic value to payers and, most importantly, extend and enhance
the lives of patients.”
Brian
joined Bristol-Myers Squibb in 2000 as vice president of the
Immunology, Pulmonary, and Dermatology therapeutic area, where
he provided strategic oversight and led the early development
of compounds including ORENCIA and belatacept.
In
2002, Brian was promoted to vice president, Full Development,
providing leadership to the development of six key clinical programs
including REYATAZ and BARACLUDE. He also led efforts to improve
productivity and to standardize and integrate the global execution
of clinical trials as vice president of Global Development Operations.
He was appointed senior vice president, Global Clinical Development
in 2004, and to his current position in March 2008.
Prior
to joining Bristol-Myers Squibb, Brian spent four years at Merck
Research Laboratories in clinical research, where he held the
role of senior director, Pulmonary and Immunology. He has also
worked in clinical research at Genentech.
Brian
is married and has a son, 18, and a daughter, 16. Next to spending time with his
family, what he enjoys most is gardening. “It’s sort
of like simplified drug development,” he says. “It
takes a lot of careful tending to develop a great garden. But
when you’re successful, it’s a beautiful thing.”
Brian
holds bachelor’s and master’s degrees in biology
from the Massachusetts Institute of Technology and a medical
degree from Washington University School of Medicine. He received
training in internal medicine at New York Hospital and in rheumatology
at the University of California in San Francisco.
May, 2008 |
